Developing a medical device and other therapies for type 2 diabetes and obesity.
Industry: Health Care
Latest Trade: $3.13 0.00 (0.0%)
First Day Return: -14.3%
Return from IPO: -79.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/14/2023 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 7.3 |
Deal Size ($mm) | $110 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/01/2024 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 7.3 |
Deal Size ($mm) | $110 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Morgan Stanley |
more |
Company Data | |
---|---|
Headquarters | Lexington, MA, United States |
Founded | 2010 |
Employees at IPO | 88 |
Website www.fractyl.com |